In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

InflaRx (IFRX) outlined multiple data analyses of the Phase 3 study for vilobelimab in pyoderma gangrenosum, which was terminated earlier this ...

Crohn's disease is a chronic inflammatory bowel disease that requires long-term medical and surgical management to improve quality of life.

Pyoderma gangrenosum lesion regression after dapsone treatment. However, after two weeks, the patient’s hematological condition deteriorated, presenting with a hemoglobin level of 7 g/dL, white blood ...

Background: Pyoderma gangrenosum (PG) is a rare dermatosis often associated with systemic diseases. There are autoinflammatory mechanisms with neutrophilic infiltrate and necrosis. Due to the high ...

Department of Internal Medicine, Dermatology and Allergology, the Specialist Hospital, Zabrze, Poland Department of Dermatology in Zabrze, Silesian Medical University in Katowice, Poland Pyoderma ...

ABSTRACT: Hidradenitis suppurativa (HS) is a refractory and recurrent chronic inflammatory skin disease characterized by nodules, abscesses, sinus tracts, and scarring. The etiology of HS remains ...